Jun 2026 (Q2 FY26) — Aug 5, 2026
Celanese Q2 FY26 — Strong Free Cash Flow and Strategic Growth in Engineered Materials
Read the full callCelanese (CE) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Celanese earnings: last reported Wed, 5 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 2,752 | +8.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 10.0 | +0.9 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 125 | −36.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Guidance
What management said, and what became of it
2 of 2 judged targets kept · 18 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Additional savings in Engineered Materials | $30 million to $50 million | Sep 2025 | Look, I think the EM footprint actions, think about $30 million, $35 million | Revised Down |
| Cost benefit from Lanaken closure | $5 million to $10 million | Dec 2025 | We'll probably get 1/3 or so of the Lanaken cost savings this year | On Track |
18 of Celanese Corp's 20 targets are still open. See which are on track and which have gone quiet. The 2 above are the free sample; 18 more targets are in the full ledger.
Claimed
- Acetyl Chain (AC) demonstrated strong resiliency and flexibility, leveraging its global production network to ensure reliable supply.
- Engineered Materials (EM) adjusted EBIT is expected to grow at double-digit rates, closer to 15%, for FY26 despite significant headwinds.
- Generated $140M in free cash flow in Q2 FY26, with confidence in achieving $700M-$800M for the full year.
- Commitment to $1B divestiture target by end of 2027 remains firm, with $500M remaining and at least one deal expected by year-end FY26.
- EM is successfully driving mix enrichment and penetration into high-value subsegments like data centers and medical, contributing significantly to margins.
Qualified
- Ibn Sina equity earnings are expected to be $10M lower than anticipated for FY26, primarily impacting Q3.
- Higher inventory absorption hit anticipated in H2 FY26 due to accelerated Lanaken plant closure and EM closures.
- Raw material cost inflation in Engineered Materials is expected to flow through in Q3 FY26, potentially causing margin compression.
- Acetate tow business continues to experience some destocking pressure in H2 FY26, though at a slower pace.
Price
$47.88 +0.82% · +$0.39
Performance +19.1% 1Y
1Y: $40.19 on 17 Oct 2025 → $47.88. High $69.24 (1 May 2026), low $35.53 (20 Nov 2025).
- Previous close
- $47.49
- 52-week range
- $35.53 – $69.24
- One year
- +16.67%
Overview
- Symbol
- CE
- Sector
- Materials
- Exchange
- US
- Currency
- USD
Guidance
What management said, and what became of it
2 of 2 judged targets kept · 18 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Additional savings in Engineered Materials | $30 million to $50 million | Sep 2025 | Look, I think the EM footprint actions, think about $30 million, $35 million | Revised Down |
| Cost benefit from Lanaken closure | $5 million to $10 million | Dec 2025 | We'll probably get 1/3 or so of the Lanaken cost savings this year | On Track |
Claimed
- Acetyl Chain (AC) demonstrated strong resiliency and flexibility, leveraging its global production network to ensure reliable supply.
- Engineered Materials (EM) adjusted EBIT is expected to grow at double-digit rates, closer to 15%, for FY26 despite significant headwinds.
- Generated $140M in free cash flow in Q2 FY26, with confidence in achieving $700M-$800M for the full year.
- Commitment to $1B divestiture target by end of 2027 remains firm, with $500M remaining and at least one deal expected by year-end FY26.
- EM is successfully driving mix enrichment and penetration into high-value subsegments like data centers and medical, contributing significantly to margins.
Qualified
- Ibn Sina equity earnings are expected to be $10M lower than anticipated for FY26, primarily impacting Q3.
- Higher inventory absorption hit anticipated in H2 FY26 due to accelerated Lanaken plant closure and EM closures.
- Raw material cost inflation in Engineered Materials is expected to flow through in Q3 FY26, potentially causing margin compression.
- Acetate tow business continues to experience some destocking pressure in H2 FY26, though at a slower pace.
The full ledger
Open Celanese Corp’s full ledger
A free account opens 5 company ledgers a month. All 20 tracked commitments, with each call’s wording and source.
Call summaries
Mar 2026 (Q1 FY26) — May 6, 2026
Celanese Q1 FY26 — Strong Q2 Acetyl Chain Performance and Strategic Nylon 66 Restructuring
Read the full callEvery analysed call
Celanese earnings calls (CE)
Financials
What the filings say
Net profit, year on year: −37% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,648 | 2,370 | 2,389 | 2,532 | 2,419 | 2,204 | 2,337 | 2,752 |
| Operating profit | 245 | -1,405 | 165 | 231 | -1,275 | 93 | 214 | 276 |
| Operating margin | 9.3% | −59.3% | 6.9% | 9.1% | −52.7% | 4.2% | 9.2% | 10.0% |
| Interest | 169 | 164 | 170 | 177 | 177 | 177 | 183 | 186 |
| Profit before tax | 180 | -1,519 | -6 | 133 | -1,360 | 13 | 82 | 142 |
| Tax rate | 33.9% | −25.5% | −150.0% | −57.9% | 0.5% | −115.4% | 40.2% | 7.8% |
| Net profit | 113 | -1,914 | -24 | 197 | -1,357 | 19 | 44 | 125 |
| EPS ($ per share) | 1.03 | — | -0.22 | 1.80 | -12.39 | — | 0.40 | 1.14 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 5,847 | 6,399 | 8,091 | 9,677 | 11,274 | 12,929 | 11,054 | 9,876 |
| Total liabilities | 5,934 | 6,578 | 7,014 | 7,438 | 20,167 | 19,071 | 17,275 | 17,223 |
| Fixed assets | 3,719 | 3,713 | 3,939 | 4,193 | 5,584 | 5,584 | 5,273 | 5,076 |
| Investments | 31 | 40 | 533 | 10 | — | — | — | — |
| Total assets | 9,313 | 9,476 | 10,909 | 11,975 | 26,272 | 26,597 | 22,838 | 21,695 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1,558 | 1,454 | 1,343 | 1,757 | 1,819 | 1,899 | 966 | 1,146 |
| Cash from investing | -507 | -493 | 592 | -1,119 | -11,141 | -134 | -470 | -349 |
| Cash from financing | -1,165 | -935 | -1,471 | -1,042 | 10,290 | -1,456 | -1,313 | -513 |
| Net cash flow | -137 | 24 | 492 | -419 | 972 | 297 | -843 | 301 |
| Capital expenditure | -337 | -370 | -364 | -467 | -543 | -568 | -435 | -343 |
| Free cash flow | 1,221 | 1,084 | 979 | 1,290 | 1,276 | 1,331 | 531 | 803 |
CE revenue by segment
Acetyl Chain grew from 44% to 47% of revenue over the last two years.
| Segment | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Engineered Materials | 56% | 54% | 54% | 57% | 57% | 58% | 57% | 53% | +0.3% |
| Acetyl Chain | 44% | 46% | 46% | 43% | 43% | 42% | 43% | 47% | +19.8% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Revenue by region
Q2 FY2026 · share of revenue
- EMEA 35% ↑ 4 pt
- Asia Pacific 33% ↓ 3 pt
- North America 29% ↓ 1 pt
- South America 3%
As CE cuts its regions in its filings; they can nest, so they need not add to 100%.
Insider filings
40 filings between Nov 17, 2025 and Aug 14, 2026.
Open market
decisions to buy or sellPurchases
$593.3K
7 purchases by 4 insiders
Sales
None
No insider sold shares.
Compensation
not trading decisions- 23
- Award — granted as compensation
- 6
- Tax withheld — shares kept back by the company to cover tax
Also filed: 3 dispositions to the issuer, 1 conversion.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Kyrish Chuck | $309.8K | — | Aug 14, 2026 |
| Richardson Scott A | $158.0K | — | Dec 10, 2025 |
| Murray Mark Christopher | $98.0K | — | Aug 11, 2026 |
| Duffie Ashley B | $27.4K | — | Aug 11, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | Kyrish Chuck SVP & CFO | Purchase | 100 | $4.6K |
| Aug 14, 2026 | Kyrish Chuck SVP & CFO | Purchase | 800 | $36.4K |
| Aug 14, 2026 | Kyrish Chuck SVP & CFO | Purchase | 1,400 | $63.7K |
| Aug 11, 2026 | Duffie Ashley B SVP & GC | Purchase | 600 | $27.4K |
| Aug 11, 2026 | Murray Mark Christopher SVP - Acetyls | Purchase | 2,153 | $98.0K |
| Aug 10, 2026 | GALANTE EDWARD G Director | Award | 1,930 | $0 |
| May 11, 2026 | Chinn Bruce E. Director | Award | 2,975 | $0 |
| May 11, 2026 | GALANTE EDWARD G Director | Award | 4,676 | $0 |
| May 11, 2026 | MOORTHY GANESH Director | Award | 2,975 | $0 |
| May 11, 2026 | Rucker Kim K.W. Director | Award | 2,975 | $0 |
| May 11, 2026 | Hill Kathryn Director | Award | 2,975 | $0 |
| May 11, 2026 | Kuehn Christopher J Director | Award | 2,975 | $0 |
| May 11, 2026 | Noonan Anne P Director | Award | 2,975 | $0 |
| May 11, 2026 | Kissire Deborah J. Director | Award | 2,975 | $0 |
| May 11, 2026 | Koenig Michael Director | Award | 2,975 | $0 |
| May 9, 2026 | Kuehn Christopher J Director | Disposition to issuer | 3,376 | — |
| May 9, 2026 | Rucker Kim K.W. Director | Disposition to issuer | 3,376 | — |
| May 9, 2026 | Koenig Michael Director | Tax withheld | 1,013 | $58.3K |
| May 9, 2026 | Kissire Deborah J. Director | Disposition to issuer | 3,376 | — |
| Feb 27, 2026 | Elliott Todd L SVP, EM | Award | 12,579 | $0 |
| Feb 27, 2026 | Duffie Ashley B SVP & GC | Award | 10,431 | $0 |
| Feb 27, 2026 | Kyrish Chuck SVP & CFO | Award | 15,678 | $0 |
| Feb 27, 2026 | McGilvray Aaron M Chief Accounting Officer | Award | 1,687 | $0 |
| Feb 27, 2026 | Murray Mark Christopher SVP - Acetyls | Award | 10,431 | $0 |
| Feb 27, 2026 | Richardson Scott A CEO & President | Award | 50,623 | $0 |
| Feb 15, 2026 | Duffie Ashley B SVP & GC | Award | 618 | $0 |
| Feb 15, 2026 | Duffie Ashley B SVP & GC | Tax withheld | 183 | $10.8K |
| Feb 15, 2026 | Kyrish Chuck SVP & CFO | Award | 401 | $0 |
| Feb 15, 2026 | Kyrish Chuck SVP & CFO | Tax withheld | 179 | $10.6K |
| Feb 15, 2026 | McGilvray Aaron M Chief Accounting Officer | Award | 173 | $0 |
| Feb 15, 2026 | McGilvray Aaron M Chief Accounting Officer | Tax withheld | 188 | $11.1K |
| Feb 15, 2026 | Murray Mark Christopher SVP - Acetyls | Award | 1,205 | $0 |
| Feb 15, 2026 | Murray Mark Christopher SVP - Acetyls | Tax withheld | 357 | $21.1K |
| Feb 15, 2026 | Richardson Scott A CEO & President | Award | 3,336 | $0 |
| Feb 15, 2026 | Richardson Scott A CEO & President | Tax withheld | 989 | $58.5K |
| Jan 1, 2026 | Hill Kathryn Director | Conversion | 1,808 | $0 |
| Dec 10, 2025 | Richardson Scott A CEO & President | Purchase | 3,800 | $158.0K |
| Dec 9, 2025 | Kyrish Chuck SVP & CFO | Purchase | 5,000 | $205.2K |
| Nov 17, 2025 | Duffie Ashley B SVP & GC | Award | 6,624 | $0 |
| Nov 17, 2025 | McGilvray Aaron M Chief Accounting Officer | Award | 2,980 | $0 |
| Sep 8, 2025 | Go Timothy Director | Purchase | 539 | $24.9K |
| Sep 8, 2025 | Go Timothy Director | Purchase | 500 | $23.2K |
| Aug 14, 2025 | GALANTE EDWARD G Director | Purchase | 2,400 | $99.1K |
| Aug 14, 2025 | MOORTHY GANESH Director | Purchase | 1,000 | $40.9K |
| Aug 14, 2025 | Sutton Scott McDougald Director | Purchase | 2,000 | $81.8K |
| Aug 14, 2025 | Murray Mark Christopher SVP - Acetyls | Purchase | 2,017 | $84.4K |
| Jul 13, 2025 | Murray Mark Christopher SVP - Acetyls | Tax withheld | 485 | $29.5K |
| May 23, 2025 | Murray Mark Christopher SVP - Acetyls | Purchase | 1,479 | $77.2K |
| May 15, 2025 | Go Timothy Director | Disposition to issuer | 1,114 | — |
| May 15, 2025 | Kissire Deborah J. Director | Disposition to issuer | 1,114 | — |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Celanese Corp
Free account. Everything above stays public.
Write why you follow Celanese Corp and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading